|
Delayed
NSE India S.E.
08:49:11 09/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1,959.40 INR | +0.91% |
|
+0.45% | +38.04% |
| 11-05 | Ipca Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 | CI |
| 11-05 | Ipca Laboratories Limited, Q2 2027 Earnings Call, Nov 05, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPCA LABORATORIES LIMITED | Other Pharmaceuticals | +0.91% | +0.45% | +38.04% | +45.65% | +79.51% | 5.23B |  | | |
- Stock Market
- Stocks
- IPCALAB Stock
- Charts Ipca Laboratories Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
